1. Home
  2. APYX vs CNTB Comparison

APYX vs CNTB Comparison

Compare APYX & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.51

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.54

Market Cap

128.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
CNTB
Founded
1982
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.2M
128.6M
IPO Year
1987
2021

Fundamental Metrics

Financial Performance
Metric
APYX
CNTB
Price
$3.51
$2.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$7.00
$8.50
AVG Volume (30 Days)
57.1K
152.2K
Earning Date
11-06-2025
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,902,000.00
$762,000.00
Revenue This Year
$8.41
N/A
Revenue Next Year
$7.01
$24,739.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.51
52 Week High
$4.44
$3.28

Technical Indicators

Market Signals
Indicator
APYX
CNTB
Relative Strength Index (RSI) 42.53 51.39
Support Level $3.35 $2.50
Resistance Level $3.65 $2.89
Average True Range (ATR) 0.16 0.24
MACD -0.04 0.01
Stochastic Oscillator 25.00 59.48

Price Performance

Historical Comparison
APYX
CNTB

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Share on Social Networks: